| 05/05/2026 3:06 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/28/2026 3:05 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEFA14A | |
| 04/28/2026 7:58 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/09/2026 3:26 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEF 14A | |
| 03/31/2026 10:17 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form PRE 14A | |
| 03/25/2026 3:05 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/24/2026 8:08 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 3:32 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/16/2026 3:05 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEFA14A | |
| 02/23/2026 3:18 PM | Shirvan Mitchell (1727789) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:20 PM | Alon Ruth (1796386) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SLXNW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Silexion Therapeutics Corp - Warrant and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/23/2026 3:11 PM | Peled Amnon (2048879) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 3:13 PM | Abramov Dror Yosef (2034083) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/13/2026 3:49 PM | INTRACOASTAL CAPITAL, LLC (1646799) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G/A | |
| 02/13/2026 3:09 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form PRE 14A | |
| 02/03/2026 8:50 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/27/2026 10:03 AM | Levin Ilan (1849189) Reporting Moringa Sponsor, LP (1849192) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 7:24 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/31/2025 12:00 PM | Peled Amnon (2048879) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 12:04 PM | Lushi Avner (2033604) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 12:07 PM | Noy Shlomo (2033211) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 12:09 PM | Alon Ruth (1796386) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/31/2025 12:13 PM | Abramov Dror Yosef (2034083) Reporting Silexion Therapeutics Corp - Warrant (2022416) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/16/2025 7:48 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/02/2025 7:33 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/25/2025 8:25 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/12/2025 8:01 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 8:07 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/31/2025 4:06 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/30/2025 11:15 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form EFFECT | |
| 09/30/2025 8:05 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/26/2025 3:30 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form S-3 Registration statement under Securities Act of 1933 | |
| 09/26/2025 3:05 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/25/2025 7:00 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/23/2025 10:17 AM | Moringa Sponsor, LP (1849192) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13D/A | |
| 09/18/2025 4:47 PM | Lind Global Fund III LP (2071860) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G | |
| 09/17/2025 4:14 PM | INTRACOASTAL CAPITAL, LLC (1646799) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G | |
| 09/15/2025 4:19 PM | Orca Capital AG (2052389) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G | |
| 09/15/2025 4:23 PM | Orca Capital AG (2052389) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G/A | |
| 09/15/2025 3:35 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2025 11:31 AM | Lincoln Alternative Strategies LLC (2043812) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G | |
|
| 09/12/2025 3:30 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/12/2025 7:33 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B4 | |
| 09/11/2025 11:15 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form EFFECT | |
| 09/11/2025 6:31 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/05/2025 3:17 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 09/04/2025 11:15 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form EFFECT | |
| 09/04/2025 4:29 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/04/2025 8:30 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 09/02/2025 7:31 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2025 3:08 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 08/20/2025 4:17 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 08/19/2025 9:05 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2025 3:14 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 08/12/2025 3:16 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 08/12/2025 3:19 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 08/12/2025 9:31 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEFA14A | |
| 08/12/2025 7:31 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/11/2025 5:02 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form D Notice of Exempt Offering of Securities | |
| 08/01/2025 11:23 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 08/01/2025 11:23 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 08/01/2025 11:29 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/31/2025 11:17 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/31/2025 8:13 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEF 14A | |
| 07/29/2025 8:10 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/21/2025 11:05 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form PRE 14A | |
| 07/16/2025 7:55 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/14/2025 3:05 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/09/2025 8:15 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/08/2025 3:05 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K/A | |
| 07/08/2025 8:35 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/07/2025 8:29 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEFA14A | |
| 06/26/2025 3:15 PM | Silexion Therapeutics Corp - Warrant (2022416) Subject Wildcat Capital Management, LLC (1582384) Filed by | Form SCHEDULE 13D/A | |
| 06/23/2025 3:48 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEFA14A | |
| 06/16/2025 9:51 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form DEF 14A | |
| 05/29/2025 11:15 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form EFFECT | |
| 05/29/2025 9:14 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2025 3:04 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form POS AM | |
| 05/23/2025 4:00 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/21/2025 8:20 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/13/2025 4:01 PM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |
| 05/13/2025 10:36 AM | GOLDMAN SACHS GROUP INC (886982) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G/A | |
| 05/12/2025 11:12 AM | CVI Investments, Inc. (1649553) Filed by Silexion Therapeutics Corp - Warrant (2022416) Subject | Form SCHEDULE 13G/A | |
| 05/06/2025 7:35 AM | Silexion Therapeutics Corp - Warrant (2022416) Filer | Form 424B3 | |